Jessica Newcomb
CIK: 0002130408
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TNGX
Tango Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Newcomb Jessica
Newcomb Jessica (SEC CIK 0002130408) files insider reports with the SEC as Principal Accounting Officer of Tango Therapeutics, Inc. (TNGX).
Signal8 holds 2 ownership filings by Newcomb Jessica (1 Form 3, 1 Form 4), filed between Apr 24, 2026 and Sep 24, 2026. Those filings report 3 transactions, the latest on Sep 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Newcomb Jessica's filings is in BOSTON, MA.
Recent filings by Newcomb Jessica
- Sep 22, 2026: Open-market sales of TNGX shares (3 lines, Form 4, code S).
Other insiders filing for Tango Therapeutics, Inc. (TNGX)
- Crystal Adam, President, R&D
- Azelby Robert, Director
- Ketchum John B, Director
- Calhoun Lesley Ann, Director
- Rothenberg Mace, Director
- Lee Sung, Director